COMPANY PROFILE // THE 014 REPORT
Bright Minds Biosciences Inc.
DRUG (Nasdaq)
Assembled from 2 government sources in 2.8 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
No flag from the records checked. 26 of 26 lists and sources checked came back clear (panel below).
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
BRIGHT MINDS BIOSCIENCES INC. is an SEC-registered company in pharmaceutical preparations, incorporated in British Columbia, Canada, based in Chicago, IL; listed as DRUG (Nasdaq).[source] It has filed 38 documents with the SEC in the last 12 months; the latest is a SCHEDULE 13G/A, filed 2026-11-16.[source] Its largest institutional holders on 13F filings are Jupiter Topco LLC, Cormorant Asset Management, LP, BlackRock, Inc. (as of 2026-06-30).[source] Every list and source checked for this page came back clear (26 of 26), dated in the checks panel.[source]
- red0
- amber0
- info0
- Jupiter Topco LLC$94.8M
- Cormorant Asset Management, LP$63.2M
- BlackRock, Inc.$48.2M
- Vivo Capital, LLC$39.1M
- Vestal Point Capital, LP$38.3M
- BRAIDWELL LP$34.0M
- Driehaus Capital Management LLC$30.4M
- Balyasny Asset Management L.P.$24.2M
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Legal counsel, as publicly named
- McMillan LLP · Exhibit 5.1 legal opinion, S-8 filed 2026-08-13
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001827401 | source |
| EIN | 00-0000000 | source |
| Business address (SEC) | 400 N ABERDEEN ST SUITE 900, CHICAGO, IL, 60642 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-01-28 · in 69 days · Next 20-F due (period ended 2026-09-30; <br>Emerging growth company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
- Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
- ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
- ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
- TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
- NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
- Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
- Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
- SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
- Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
- UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
- Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)
ADDRESS · ZIP CODE
Location context
At the same address (2)
- CHICAGO BIOTECHNOLOGY EXCHANGE INC · IRS-registered organization
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-02 filing 6-K · SEC EDGAR
- 2026-10-02 filing 6-K · SEC EDGAR
- 2026-10-01 filing 6-K · SEC EDGAR
- 2026-08-17 filing 6-K · SEC EDGAR
- 2026-08-13 filing S-8 · SEC EDGAR
- 2026-07-02 filing SCHEDULE 13D/A · SEC EDGAR
- 2026-06-03 filing 6-K · SEC EDGAR
- 2026-06-02 filing 6-K · SEC EDGAR
- 2026-05-28 filing 6-K · SEC EDGAR
- 2026-05-20 filing 6-K · SEC EDGAR
- 2026-02-13 filing 6-K · SEC EDGAR
- 2026-01-09 filing 6-K · SEC EDGAR
- 2026-01-09 filing 6-K · SEC EDGAR
- 2026-01-09 filing 424B5 · SEC EDGAR
- 2026-01-08 filing 6-K · SEC EDGAR
- 2026-01-07 filing 6-K · SEC EDGAR
- 2026-01-07 filing FWP · SEC EDGAR
- 2026-01-07 filing FWP · SEC EDGAR
- 2026-01-07 filing 424B5 · SEC EDGAR
- 2026-01-07 filing 6-K · SEC EDGAR
- 2026-01-06 filing 6-K · SEC EDGAR
- 2026-01-05 filing 6-K · SEC EDGAR
- 2025-12-23 filing F-X · SEC EDGAR
- 2025-12-23 filing 40-F · SEC EDGAR
- 2025-11-17 filing 6-K · SEC EDGAR
- 2025-11-17 filing 6-K/A · SEC EDGAR
- 2025-11-07 filing 6-K · SEC EDGAR
- 2025-11-07 filing 6-K · SEC EDGAR
- 2025-09-05 filing 6-K · SEC EDGAR
- 2025-09-02 filing EFFECT · SEC EDGAR
114 earlier entries
- 2025-08-28 filing CORRESP
- 2025-08-27 filing UPLOAD
- 2025-08-26 filing F-3
- 2025-08-15 filing 6-K
- 2025-08-11 filing 6-K
- 2025-05-28 filing 6-K
- 2025-05-21 filing 6-K
- 2025-05-14 filing 6-K
- 2025-04-29 filing 6-K
- 2025-03-05 filing 6-K
- 2025-02-24 filing 6-K
- 2025-02-14 filing EFFECT
- 2025-02-14 filing 424B3
- 2025-02-14 filing 6-K
- 2025-02-12 filing CORRESP
- 2025-02-11 filing UPLOAD
- 2025-02-05 filing F-3
- 2025-01-08 filing 6-K
- 2024-12-31 filing Annual report (20-F)
- 2024-11-21 filing 6-K
- 2024-11-19 filing D
- 2024-11-05 filing SC 13D/A
- 2024-11-05 filing SC 13D/A
- 2024-11-05 filing 6-K
- 2024-10-22 filing D
- 2024-10-21 filing 6-K
- 2024-10-18 filing 6-K
- 2024-10-16 filing 6-K
- 2024-10-16 filing 6-K
- 2024-10-03 filing 6-K
- 2024-09-12 filing 6-K
- 2024-08-15 filing 6-K
- 2024-05-17 filing 6-K
- 2024-05-17 filing 6-K
- 2024-05-03 filing D
- 2024-02-26 filing SC 13D/A
- 2024-02-26 filing SC 13D/A
- 2024-02-13 filing 6-K
- 2024-01-18 filing SC 13D
- 2023-12-29 filing Annual report (20-F)
- 2023-12-26 filing 6-K
- 2023-12-08 filing 6-K
- 2023-08-15 filing 6-K
- 2023-08-08 filing 6-K
- 2023-07-20 filing 6-K
- 2023-07-12 filing 6-K
- 2023-06-22 filing 6-K
- 2023-05-15 filing 6-K
- 2023-04-19 filing 6-K
- 2023-04-10 filing 6-K
- 2023-03-02 filing 6-K
- 2023-02-27 filing 6-K
- 2023-02-17 filing 6-K
- 2023-02-08 filing 6-K
- 2023-02-07 filing 6-K
- 2023-01-30 filing 6-K
- 2023-01-27 filing 6-K
- 2022-12-29 filing Annual report (20-F)
- 2022-12-06 filing 6-K
- 2022-11-29 filing 6-K
- 2022-11-23 filing 6-K
- 2022-09-14 filing D
- 2022-09-08 filing 6-K
- 2022-09-08 filing 6-K
- 2022-09-01 filing D
- 2022-08-30 filing 6-K
- 2022-08-29 filing 6-K
- 2022-08-24 filing 6-K
- 2022-08-23 filing 6-K
- 2022-08-18 filing 6-K
- 2022-08-15 filing 6-K
- 2022-05-16 filing 6-K
- 2022-05-12 filing 6-K
- 2022-05-03 filing D
- 2022-05-03 filing D
- 2022-05-02 filing 6-K
- 2022-04-19 filing 6-K
- 2022-03-14 filing 6-K
- 2022-03-08 filing 6-K
- 2022-03-02 filing 6-K
- 2022-02-15 filing 6-K
- 2022-01-18 filing 20-F/A
- 2022-01-05 filing 6-K
- 2021-12-29 filing Annual report (20-F)
- 2021-11-30 filing 6-K
- 2021-11-04 filing CERT
- 2021-11-03 filing 6-K
- 2021-11-02 filing 8-A12B
- 2021-10-19 filing 6-K
- 2021-09-27 filing 6-K
- 2021-09-27 filing UPLOAD
- 2021-09-17 filing 6-K
- 2021-09-17 filing 6-K
- 2021-09-17 filing 20FR12G/A
- 2021-09-16 filing CORRESP
- 2021-09-15 filing UPLOAD
- 2021-08-27 filing CORRESP
- 2021-08-27 filing 20FR12G/A
- 2021-08-24 filing UPLOAD
- 2021-08-18 filing 6-K
- 2021-08-13 filing CORRESP
- 2021-08-13 filing 20FR12G/A
- 2021-08-04 filing UPLOAD
- 2021-07-29 filing 20FR12G/A
- 2021-07-28 filing CORRESP
- 2021-07-16 filing UPLOAD
- 2021-06-25 filing D
- 2021-06-17 filing 20FR12G
- 2021-05-04 filing D
- 2021-03-23 filing D
- 2020-11-17 filing D
- 2020-11-17 filing D
- 2020-10-07 filing D
- 2020-10-06 filing D
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-02 (within 30 days) 6-K filed
- 2026-10-02 (older) 6-K filed (FORM 6-K)
- 2026-10-01 (older) 6-K filed (FORM 6-K)
- 2026-08-17 (older) 6-K filed (FORM 6-K)
- 2026-08-13 (older) S-8 filed (FORM S-8)
- 2026-06-03 (older) 6-K filed (FORM 6-K)
- 2026-06-02 (older) 6-K filed (FORM 6-K)
- 2026-05-28 (older) 6-K filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:DRUG The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
0 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1827401 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | DRUG / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| CUSIP | 10919W405 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001827401 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | other | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
| State of incorporation | A1 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
| Fiscal year end (MMDD) | 0930 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
| Business address | 400 N ABERDEEN ST SUITE 900, CHICAGO, IL, 60642 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Form D total offering amount (D filed 2024-11-19) | $34,599,955 | 2024-11-19 | D | as filed | 2026-11-20 10:22 UTC | Report an error |
| Form D total amount sold (D filed 2024-11-19) | $34,599,955 | 2024-11-19 | D | as filed | 2026-11-20 10:22 UTC | Report an error |
| Form D industry group | Biotechnology | 2024-11-19 | D | as filed | 2026-11-20 10:22 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2024-11-19 | D | as filed | 2026-11-20 10:22 UTC | Report an error |
| Form D date of first sale | 2024-11-04 | 2024-11-19 | D | as filed | 2026-11-20 10:22 UTC | Report an error |
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-02 Filing 6-K filed
- 2026-10-02 Filing 6-K filed (FORM 6-K)
- 2026-10-01 Filing 6-K filed (FORM 6-K)
- 2026-08-17 Filing 6-K filed (FORM 6-K)
- 2026-08-13 Filing S-8 filed (FORM S-8)
- 2026-06-03 Filing 6-K filed (FORM 6-K)
- 2026-06-02 Filing 6-K filed (FORM 6-K)
- 2026-05-28 Filing 6-K filed
- 2026-05-20 Filing 6-K filed (FORM 6-K)
- 2026-02-13 Filing 6-K filed (FORM 6-K)
- 2026-01-09 Filing 6-K filed (FORM 6-K)
- 2026-01-09 Filing 6-K filed (FORM 6-K)
- 2026-01-09 Filing 424B5 filed (FORM 424B5)
- 2026-01-08 Filing 6-K filed
- 2026-01-07 Filing 6-K filed (FORM 6-K)
- 2026-01-07 Filing FWP filed (FORM FWP)
- 2026-01-07 Filing FWP filed (FORM FWP)
- 2026-01-07 Filing 424B5 filed (FORM 424B5)
- 2026-01-07 Filing 6-K filed
- 2026-01-06 Filing 6-K filed
- 2026-01-05 Filing 6-K filed
- 2025-12-23 Filing F-X filed (FORM F-X)
- 2025-12-23 Filing 40-F filed (FORM 40-F)
- 2025-11-17 Filing 6-K filed (FORM 6-K)
- 2025-11-17 Filing 6-K/A filed (FORM 6-K/A)
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | Jupiter Topco LLC | $94,821,986 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 2 | Cormorant Asset Management, LP | $63,180,000 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 3 | BlackRock, Inc. | $48,170,117 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 4 | Vivo Capital, LLC | $39,113,474 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 5 | Vestal Point Capital, LP | $38,259,000 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 6 | BRAIDWELL LP | $33,964,304 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 7 | Driehaus Capital Management LLC | $30,423,065 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 8 | Balyasny Asset Management L.P. | $24,222,721 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 9 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $23,517,000 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 10 | Point72 Asset Management, L.P. | $22,984,603 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1827401.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001827401. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.